Tesla’s Bold Gamble – Robotaxis, Rising Sales, and the High-Stakes Road to AutonomySeptember 24, 2024
Director James Cameron explains why he is joining Stability AI’s board of directorsSeptember 24, 2024
Tesla’s Bold Gamble – Robotaxis, Rising Sales, and the High-Stakes Road to AutonomySeptember 24, 2024
Director James Cameron explains why he is joining Stability AI’s board of directorsSeptember 24, 2024
Share Facebook Twitter LinkedIn Pinterest Email Michelle Ross, StemPoint Capital CIO and Novo Nordisk shareholder, joins CNBC’s ‘Closing Bell’ to discuss the criticism Novo has faced around high drug prices, the potential earnings impact if prices come down, and more.